Funded Tech Companies
Elixir Pharmaceuticals
Wondering who invested in Elixir Pharmaceuticals? Novartis Venture Fund, Physic Ventures and Arch Venture Partners invested in this biopharmaceutical company.
Company Overview
Company Name
Elixir Pharmaceuticals
Company Status
Out of Business
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
300 Putnam Avenue
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Elixir Pharmaceuticals is a genomics-based drug discovery company developing a new category of pharmaceuticals that treat and/or prevent the broad spectrum of diseases that accompany aging.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/19/2009
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Medical Officer
Paul Martha
Chief Scientific Officer
Peter DiStefano
VP - Finance
Karen Roberts
Company Investors
- Novartis Venture Fund
- Physic Ventures (Dion Madsen)
- Arch Venture Partners (Robert Nelsen)
- MPM Capital (Kenneth Greenberg)
- Oxford Bioscience Partners (Jonathan Fleming)
- MPM Capital (Vaughn Kailian)
- CDIB Bioscience
- Rally Ventures
- MPM Capital (Ansbert Gaedcke)
- H.I.G. Capital
- MPM Capital (Ansbert Gadicke)
Browse more funded tech companies:
Elixir Games | Elixir Technologies
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs